Chemours (CC) Equity Income (2014 - 2026)

Chemours has reported Equity Income for 13 years, with the latest figure at $8.0 million in Q1 2026.

• For the quarter ending Q1 2026, Equity Income changed 0.0% year-over-year to $8.0 million; the trailing twelve-month figure through Mar 2026 stood at $34.0 million (down 12.82% YoY), and the FY2025 full-year result was $35.0 million, down 18.6% from the prior year.
• Equity Income for Q1 2026 stood at $8.0 million, roughly flat from $8.0 million in the prior quarter.
• The five-year high for Equity Income was $16.0 million in Q2 2022, with the low at $7.0 million in Q4 2023.
• Average Equity Income over 5 years is $10.9 million, with a median of $11.0 million recorded in 2022.
• Year-over-year, Equity Income jumped 60.0% in 2022 and slumped 38.46% in 2025.
• Tracing CC's Equity Income over 5 years: stood at $11.0 million in 2022, then sank by 36.36% to $7.0 million in 2023, then climbed by 28.57% to $9.0 million in 2024, then slipped by 11.11% to $8.0 million in 2025, then changed by 0.0% to $8.0 million in 2026.
• The last three Equity Income figures came in at $8.0 million (Q1 2026), $8.0 million (Q4 2025), and $9.0 million (Q3 2025), per Business Quant data.

Peer Comparison